HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cyclopropanecarboxylic acid

0

Also Known As:

CPCA cpd; cyclopropane carboxylic acid

Networked: 6 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclopropanes: 9
        cyclopropanecarboxylic acid: 6

Experts

1.	Andersson, Ulf: 1 article (12/2019)
2.	Andreasson, Theresa: 1 article (12/2019)
3.	Bergström, Eva Lamm: 1 article (12/2019)
4.	Björkstrand, Eva: 1 article (12/2019)
5.	Bonn, Britta: 1 article (12/2019)
6.	Chang, Hui-Fang: 1 article (12/2019)
7.	Chapman, Dave: 1 article (12/2019)
8.	Davis, Andrew M: 1 article (12/2019)
9.	Ek, Margareta: 1 article (12/2019)
10.	Glader, Pernilla: 1 article (12/2019)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 09/01/2010 - "A compound from the series, (cyclopropanecarboxylic acid [5-(5-methyl-[1,2,4]oxadiazol-3-yl)-4-phenyl-thiazol-2-yl]-amide, compound 13), was shown to be effective in reversing haloperidol-induced hypolocomotion, a model of motor dysfunction in Parkinson's Disease."
2.	Asthma (Bronchial Asthma) 12/01/2019 - "Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma."
3.	Pain (Aches) 01/01/2009 - "Here, we report the identification of A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], a potent and selective CB(2) agonist as characterized in in vitro pharmacological assays and in in vivo models of pain and central nervous system (CNS) behavior models. " 01/01/2009 - "Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging."
4.	Osteoporosis 01/01/2016 - "Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis."
5.	Memory Disorders (Memory Loss) 04/09/2014 - "Here we report that 1-(3',4'-dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid) (CHF5074), a compound that favorably affects neurodegeneration, neuroinflammation and memory deficit in transgenic mouse models of AD, interacts with the AICD and impairs its nuclear activity. "

Related Drugs and Biologics

1.	Amides
2.	Leukotriene C4
3.	Haloperidol (Haldol)
4.	1- (3',4'- dichloro- 2- fluoro(1,1'- biphenyl)- 4- yl)cyclopropanecarboxylic acid
5.	diphenyl (biphenyl)
6.	Amyloid Precursor Protein Secretases (beta-Secretase)
7.	Calcium-Sensing Receptors
8.	CB2 Cannabinoid Receptor
9.	Amyloid beta-Peptides
10.	Cannabinoids